Wells Fargo raises AbbVie target price to $340 from $300
ABBV•Wells Fargo raised its target price for AbbVie to $340 from $300.
Related News
Oil drops more than 4% on talks aimed at ending US-Iran war
USO•
Ameresco hosts investor meetings at Cantor Convergence Conference
AMRC•
D-Wave Quantum: B. Riley cuts target price to $27 from $40
QBTS•
PTC Therapeutics to present at Jefferies and Citi healthcare conferences
PTCT•
Schwab survey shows 46% of retail investors bearish on US stocks in Q4
SCHW•